Trupanion, Inc. (NASDAQ:TRUP) CEO Margaret Tooth Sells 2,294 Shares

Trupanion, Inc. (NASDAQ:TRUP) CEO Margaret Tooth sold 2,294 shares of the business’s stock in a transaction that occurred on Tuesday, March 4th. The stock was sold at an average price of $31.39, for a total transaction of $72,008.66. Following the sale, the chief executive officer now directly owns 118,784 shares in the company, valued at approximately $3,728,629.76. This represents a 1.89 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Trupanion Stock Up 2.4 %

TRUP stock opened at $33.88 on Thursday. The firm’s fifty day simple moving average is $44.82 and its 200-day simple moving average is $47.65. The company has a market capitalization of $1.43 billion, a P/E ratio of -147.30, a price-to-earnings-growth ratio of 6.02 and a beta of 1.60. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.71 and a quick ratio of 1.66. Trupanion, Inc. has a 12 month low of $19.69 and a 12 month high of $57.90.

Trupanion (NASDAQ:TRUP) last announced its quarterly earnings results on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.02). Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. The firm had revenue of $337.31 million for the quarter, compared to analysts’ expectations of $335.41 million. As a group, equities research analysts forecast that Trupanion, Inc. will post 0.13 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the stock. Piper Sandler dropped their target price on shares of Trupanion from $57.00 to $52.00 and set an “overweight” rating on the stock in a research report on Thursday, February 20th. Stifel Nicolaus dropped their target price on shares of Trupanion from $44.00 to $41.00 and set a “hold” rating on the stock in a research report on Thursday, February 20th. Two equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, Trupanion has a consensus rating of “Moderate Buy” and a consensus target price of $46.60.

Institutional Trading of Trupanion

A number of hedge funds have recently added to or reduced their stakes in TRUP. Vanguard Group Inc. raised its position in Trupanion by 1.3% during the fourth quarter. Vanguard Group Inc. now owns 3,596,725 shares of the financial services provider’s stock worth $173,362,000 after acquiring an additional 45,653 shares during the period. Wellington Management Group LLP raised its position in Trupanion by 4.4% during the third quarter. Wellington Management Group LLP now owns 3,393,879 shares of the financial services provider’s stock worth $142,475,000 after acquiring an additional 142,156 shares during the period. FMR LLC raised its position in Trupanion by 55,963.7% during the third quarter. FMR LLC now owns 1,172,293 shares of the financial services provider’s stock worth $49,213,000 after acquiring an additional 1,170,202 shares during the period. Marshall Wace LLP raised its position in Trupanion by 6.9% during the fourth quarter. Marshall Wace LLP now owns 901,645 shares of the financial services provider’s stock worth $43,459,000 after acquiring an additional 57,804 shares during the period. Finally, Balyasny Asset Management L.P. raised its position in Trupanion by 368.2% during the fourth quarter. Balyasny Asset Management L.P. now owns 841,254 shares of the financial services provider’s stock worth $40,548,000 after acquiring an additional 661,559 shares during the period.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.